Search
for
Sort by
Research 301–330 of 1000+
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- The hair follicle as a neuro-immuno-endocrine organ: Implications in hair disorders and regenerative therapies
- Bioavailability File: Bicalutamide
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Acne-Associated Syndromes
- Hair and Scalp Variation Related to Gender
- MECHANISM OF ACTION OF AVICENNIA MARINA HEARTWOOD EXTRACT AND AVICEQUINONE C ON HUMAN DERMAL PAPILLA CELLS ISOLATED FROM ANDROGENIC ALOPECIA PATIENTS
- Gender Differences in Production and Circulating Levels of Sex Hormones and Their Impact on Aging Skin
- Definition criteria and diagnostic assessments
- 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA
- Main Plenary Sessions: Summaries of Papers
- Disorders of hair in children
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Prostate Carcinoma, what would be the best to do ?
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT
- A Role for Steroid 5 alpha-reductase 1 in Vascular Remodelling During Endometrial Decidualisation
- Polycystic ovarian syndrome
- Skin Diseases (Noncancerous)
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- The rationale for physiological testosterone replacement in women
- CONTRACEPTION AND THE SKIN
- Polycystic Ovary Syndrome
- Pharmacology of antiandrogens
- Hair Loss in Women
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia
- Hair Disorders